Bronchialkarzinom – Pembrolizumab Vorteilhaft Bei PD-L1-positiven Patienten

Pneumologie - Germany
doi 10.1055/s-0042-112873
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Georg Thieme Verlag KG

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy